The global dietary supplement contract manufacturing market size is anticipated to reach USD 121.2 billion by 2030, registering a CAGR of 12.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. This market involves the production of dietary supplements by a third-party manufacturer for another company. The manufacturer provides services, such as formulation, blending, mixing, encapsulation, tableting, packaging, and labeling of the supplements. The demand for dietary supplements has been increasing due to factors, such as rising health consciousness among consumers, an increasing aging population, changing lifestyles, and technological advancements. With the rise in chronic diseases and lifestyle-related disorders, people are becoming more proactive in maintaining their health. This has led to a surge in demand for dietary supplements that can help prevent or manage these conditions.
As a result, manufacturers are constantly developing new products and formulations to cater to this growing demand. The rise of e-commerce platforms and online sales channels has also contributed to market growth with the increasing popularity and accessibility of online shopping. Personalized nutrition is a growing trend in the dietary supplement industry. Consumers are increasingly seeking supplements tailored to their specific needs based on factors, such as age, gender, lifestyle, and genetic makeup. Contract manufacturers are responding to this trend by developing new technologies and processes to produce personalized supplements at scale. For instance, in March 2022, Ashland launched Nutrapress organic chewable base, designed for chewable dietary supplements. The organic base is a complete system for nutraceutical manufacturers and contains an organic binder, sweetener, flow aid, and lubricant.
The proteins & amino acid supplements product type segment dominated the market in 2023
The growth can be attributed to the increased need for supplements that contain essential amino acids along with a growing product pipeline and easy availability of specialized expertise for the development of innovative products
The tablet dosage form segment dominated the market in 2023 with a revenue share of 28.26%. Some key factors contributing to the segment growth include the convenience, ease of use, and precise dosage control offered by tablets
North America was the dominant regional market in 2023 due to the presence of key players and developed contract manufacturing capacities in North American
Please note The report will be delivered in 2-3 business days upon order notification.